ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Interview With AACR’s Margaret Foti: “The Meeting Wouldn’t Have Been The Same.”

April 4, 2003

Gigliotti Appointed Chief of Education Branch In DRCCA

January 21, 1983

Medenica Patients Drop Suit Against Doctors; Hospital To Be sold

August 19, 1994

House Figures for NCI, NIH Will Be Known This Week; Senate Probably Will Wait Until After Recess

July 31, 1987

Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research

April 27, 1979

CMS Final Rule Imposes 6 Percent Cut On Physician Fees Over Four Years

November 6, 2009